Answers are grounded in this paper and cite their sources.
Case report highlights treatment challenges and outcomes in a pediatric patient with Down syndrome and Hodgkin lymphoma, indicating the need for personalized care.
The association between Down syndrome (DS) and Hodgkin lymphoma (HL) is rare, with only a few cases reported in the literature. Here, we report the case of a pediatric patient with DS diagnosed with HL. In addition, a literature review was conducted, identifying only seven pediatric cases. We highlight treatment-related toxicity in this group of patients. Given the high survival rates of patients with HL, current strategies focus on individualizing treatment intensity based on the initial disease characteristics and the patient’s response. This consideration becomes even more important in patients with DS. The patient described in this report achieved complete metabolic remission after chemotherapy, experienced manageable grade 3 treatment-related toxicities, and remains in complete remission after 27 months of follow-up.
No takes yet. Share an insight, caveat, or question.
Queizan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: